Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations.

Shashi Sharma, Sandeep Saxena, Khushboo Srivastav, Rajendra K Shukla, Nibha Mishra, Carsten H Meyer, Peter Kruzliak, Vinay K Khanna

Journal: Clinical & experimental ophthalmology 2016;43(5):429-36

PMID: 25675974

Abstract

BACKGROUND

The aim of the study was to determine plasma nitric oxide (NO) and lipid peroxide (LPO) levels in diabetic retinopathy and its association with severity of disease.

DESIGN

Prospective observational study.

PARTICIPANTS

A total of 60 consecutive cases and 20 healthy controls were included.

METHODS

Severity of retinopathy was graded according to early treatment diabetic retinopathy study (ETDRS) classification. Photoreceptor inner segment ellipsoid band (ISel) disruption and retinal pigment epithelium (RPE) alteration were graded using spectral domain optical coherence tomography. Data were statistically analyzed.

MAIN OUTCOME MEASURES

Plasma thiobarbituric acid reactive substances, NO assay and reduced glutathione (GSH) were measured using standard protocol.

RESULTS

Increased severity of diabetic retinopathy was significantly associated with increase in plasma levels of LPO (P < 0.05), NO (P < 0.001) and decrease in plasma levels of GSH (P < 0.0001), ISel disruption (P < 0.001) and RPE topographic alteration (P < 0.01).

CONCLUSION

Increased plasma NO levels are associated with increased severity of diabetic retinopathy. For the first time, it has been demonstrated that increased plasma LPO, NO and decreased GSH levels are associated with in vivo structural changes in inner segment ellipsoid and RPE.

© 2015 Royal Australian and New Zealand College of Ophthalmologists.

Address: Retina Service, Department of Ophthalmology, King George's Medical University, Lucknow, India.; Developmental Toxicology Division, Indian Institute of Toxicology and Research, Lucknow, India.; Department of Ophthalmology, Pallas Klinik, Olten, Switzerland.; Department of Cardiovascular Diseases, International Clinical Research Center, St Anne's University Hospital and Masaryk University, Brno, Czech Republic.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.